Life Sciences

Veeva Systems announced that Gilead Sciences has adopted Veeva Vault CRM, deepening their partnership. Veeva’s next-gen CRM integrates agentic AI for pre-call planning, automated compliant communication, and voice control. Gilead expects AI to optimize sales, improve engagement, and accelerate medicine delivery. Veeva is focusing on AI-powered solutions, giving it a competitive edge in the life sciences CRM market by addressing regulatory and compliance challenges. Veeva serves over 1,500 life science customers worldwide, from pharmaceutical to biotech companies.

Avantor reaffirmed its commitment to shareholder value after Engine Capital’s letter, highlighting strategic efforts to drive growth and returns. Key actions include a new CEO appointment (Emmanuel Ligner, starting August 18, 2025), a $400M cost transformation, business resegmentation, and significant debt reduction ($1.5B). The company emphasizes its robust product portfolio, distribution network, and life sciences relationships, expressing confidence in future value creation under Ligner’s leadership and welcomes continued shareholder dialogue.

Nordicus Partners (OTCQB: NORD) expanded its Board of Directors from three to five members. Henrik Keller resigned, and Torben Jensen, Kim T. Mücke, and Andrew J. Ritter were appointed. These appointments align with Nordicus’s strategy to acquire majority stakes in Nordic and U.S. life sciences companies. The new directors bring expertise in funding, accounting, and strategic relationships, supporting Nordicus’s goal to bridge Nordic innovation with the U.S. market.